Advanced search
Publication Cover
Expert Review of Obstetrics & Gynecology Volume 7, 2012 - Issue 5
Journal homepage
3
Views
0
CrossRef citations to date
0
Altmetric
Review

Injectable bulking agents in fecal and urinary incontinence: current agents, techniques and rationale for their use

Christopher D Jaeger Department of Urology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
,
Alonso Carrasco Department of Urology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
&
Deborah J Lightner Department of Urology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. [email protected]
Pages 431-440 | Published online: 10 Jan 2014

References

  • Davila GW. Nonsurgical outpatient therapies for the management of female stress urinary incontinence: long-term effectiveness and durability. Adv. Urol. 2011, 176498 (2011).
  • Shamliyan TA, Kane RL, Wyman J, Wilt TJ. Systematic review: randomized, controlled trials of nonsurgical treatments for urinary incontinence in women. Ann. Intern. Med. 148(6), 459–473 (2008).
  • Norton C, Cody JD, Hosker G. Biofeedback and/or sphincter exercises for the treatment of faecal incontinence in adults. Cochrane Database Syst. Rev. 3, CD002111 (2006).
  • Lightner D, Fox J. Bulking agents for urinary incontinence: patient selection, counseling and technique. Expert Rev. Obstet. Gynecol. 4(6), 687–694 (2009).
  • Toozs-Hobson P, Al-Singary W, Fynes M, Tegerstedt G, Lose G. Two-year follow-up of an open-label multicenter study of polyacrylamide hydrogel (Bulkamid®) for female stress and stress-predominant mixed incontinence. Int. Urogynecol. J. 23(10), 1373–1378 (2012).
  • Lose G, Mouritsen L, Nielsen JB. A new bulking agent (polyacrylamide hydrogel) for treating stress urinary incontinence in women. BJU Int. 98(1), 100–104 (2006).
  • Murless BC. The injection treatment of stress incontinence. BJOG 45, 67–73 (1938).
  • Cespedes RD, Serkin FB. Is injection therapy for stress urinary incontinence dead? No. Urology 73(1), 11–13 (2009).
  • Kong WG, Vasavada SP. Is injection therapy for stress urinary incontinence dead? Yes. Urology 73(1), 9–10 (2009).
  • ter Meulen PH, Berghmans LC, Nieman FH, van Kerrebroeck PE. Effects of Macroplastique Implantation System for stress urinary incontinence and urethral hypermobility in women. Int. Urogynecol. J. Pelvic Floor Dysfunct. 20(2), 177–183 (2009).
  • Herschorn S, Radomski SB. Collagen injections for genuine stress urinary incontinence: patient selection and durability. Int. Urogynecol. J. Pelvic Floor Dysfunct. 8(1), 18–24 (1997).
  • Bent AE, Foote J, Siegel S, Faerber G, Chao R, Gormley EA. Collagen implant for treating stress urinary incontinence in women with urethral hypermobility. J. Urol. 166(4), 1354–1357 (2001).
  • Gumus II, Kaygusuz I, Derbent A, Simavli S, Kafali H. Effect of the Macroplastique Implantation System for stress urinary incontinence in women with or without a history of an anti-incontinence operation. Int. Urogynecol. J. 22(6), 743–749 (2011).
  • Khullar V, Cardozo LD, Abbott D, Anders K. GAX collagen in the treatment of urinary incontinence in elderly women: a two year follow up. Br. J. Obstet. Gynaecol. 104(1), 96–99 (1997).
  • Winters JC, Chiverton A, Scarpero HM, Prats LJ Jr. Collagen injection therapy in elderly women: long-term results and patient satisfaction. Urology 55(6), 856–861 (2000).
  • Wilson S, Quek ML, Ginsberg DA. Transurethral injection of bulking agents for stress urinary incontinence following orthotopic neobladder reconstruction in women. J. Urol. 172(1), 244–246 (2004).
  • Plotti F, Zullo MA, Sansone M et al. Post radical hysterectomy urinary incontinence: a prospective study of transurethral bulking agents injection. Gynecol. Oncol. 112(1), 90–94 (2009).
  • Ben-Chaim J, Jeffs RD, Peppas DS, Gearhart JP. Submucosal bladder neck injections of glutaraldehyde cross-linked bovine collagen for the treatment of urinary incontinence in patients with the exstrophy/epispadias complex. J. Urol. 154(2 Pt 2), 862–864 (1995).
  • Burki T, Hamid R, Ransley PG, Mushtaq I, Duffy PG. Injectable polydimethylsiloxane for treating incontinence in children with the exstrophy–epispadias complex: long-term results. BJU Int. 98(4), 849–853 (2006).
  • Misseri R, Casale AJ, Cain MP, Rink RC. Alternative uses of dextranomer/hyaluronic acid copolymer: the efficacy of bladder neck injection for urinary incontinence. J. Urol. 174(4 Pt 2), 1691–1691; discussion 1693 (2005).
  • Davis K, Kumar D, Poloniecki J. Preliminary evaluation of an injectable anal sphincter bulking agent (Durasphere) in the management of faecal incontinence. Aliment. Pharmacol. Ther. 18(2), 237–243 (2003).
  • Ghoniem G, Corcos J, Comiter C, Westney OL, Herschorn S. Durability of urethral bulking agent injection for female stress urinary incontinence: 2-year multicenter study results. J. Urol. 183(4), 1444–1449 (2010).
  • Richardson TD, Kennelly MJ, Faerber GJ. Endoscopic injection of glutaraldehyde cross-linked collagen for the treatment of intrinsic sphincter deficiency in women. Urology 46(3), 378–381 (1995).
  • Herschorn S, Radomski SB, Steele DJ. Early experience with intraurethral collagen injections for urinary incontinence. J. Urol. 148(6), 1797–1800 (1992).
  • Henly DR, Barrett DM, Weiland TL, O’Connor MK, Malizia AA, Wein AJ. Particulate silicone for use in periurethral injections: local tissue effects and search for migration. J. Urol. 153(6), 2039–2043 (1995).
  • Kershen RT, Atala A. New advances in injectable therapies for the treatment of incontinence and vesicoureteral reflux. Urol. Clin. North Am. 26(1), 81–94, viii (1999).
  • Dmochowski RR, Appell RA. Injectable agents in the treatment of stress urinary incontinence in women: where are we now? Urology 56(6 Suppl. 1), 32–40 (2000).
  • Kabalin JN. Treatment of post-prostatectomy stress urinary incontinence with periurethral polytetrafluoroethylene paste injection. J. Urol. 152(5 Pt 1), 1463–1466 (1994).
  • Cummings JM, Boullier JA, Parra RO. Transurethral collagen injections in the therapy of post-radical prostatectomy stress incontinence. J. Urol. 155(3), 1011–1013 (1996).
  • Klutke JJ, Subir C, Andriole G, Klutke CG. Long-term results after antegrade collagen injection for stress urinary incontinence following radical retropubic prostatectomy. Urology 53(5), 974–977 (1999).
  • Solomon LZ, Birch BR, Cooper AJ, Davies CL, Holmes SA. Nonhomologous bioinjectable materials in urology: ‘size matters’? BJU Int. 85(6), 641–645 (2000).
  • Gorton E, Stanton S, Monga A, Wiskind AK, Lentz GM, Bland DR. Periurethral collagen injection: a long-term follow-up study. BJU Int. 84(9), 966–971 (1999).
  • Lightner D, Calvosa C, Andersen R et al. A new injectable bulking agent for treatment of stress urinary incontinence: results of a multicenter, randomized, controlled, double-blind study of Durasphere. Urology 58(1), 12–15 (2001).
  • Mayer RD, Dmochowski RR, Appell RA et al. Multicenter prospective randomized 52-week trial of calcium hydroxylapatite versus bovine dermal collagen for treatment of stress urinary incontinence. Urology 69(5), 876–880 (2007).
  • Ghoniem G, Corcos J, Comiter C, Bernhard P, Westney OL, Herschorn S. Cross-linked polydimethylsiloxane injection for female stress urinary incontinence: results of a multicenter, randomized, controlled, single-blind study. J. Urol. 181(1), 204–210 (2009).
  • Harriss DR, Iacovou JW, Lemberger RJ. Peri-urethral silicone microimplants (Macroplastique) for the treatment of genuine stress incontinence. Br. J. Urol. 78(5), 722–725; discussion 726 (1996).
  • Cody J, Wyness L, Wallace S et al. Systematic review of the clinical effectiveness and cost–effectiveness of tension-free vaginal tape for treatment of urinary stress incontinence. Health Technol. Assess. 7(21), 1iii–189iii (2003).
  • Maher CF, O’Reilly BA, Dwyer PL, Carey MP, Cornish A, Schluter P. Pubovaginal sling versus transurethral Macroplastique for stress urinary incontinence and intrinsic sphincter deficiency: a prospective randomised controlled trial. BJOG 112(6), 797–801 (2005).
  • Maeda Y, Laurberg S, Norton C. Perianal injectable bulking agents as treatment for faecal incontinence in adults. Cochrane Database Syst. Rev. 5, CD007959 (2010).
  • Siproudhis L, Morcet J, Lainé F. Elastomer implants in faecal incontinence: a blind, randomized placebo-controlled study. Aliment. Pharmacol. Ther. 25(9), 1125–1132 (2007).
  • Appell RA. Collagen injection therapy for urinary incontinence. Urol. Clin. North Am. 21(1), 177–182 (1994).
  • Radley SC, Chapple CR, Mitsogiannis IC, Glass KS. Transurethral implantation of macroplastique for the treatment of female stress urinary incontinence secondary to urethral sphincter deficiency. Eur. Urol. 39(4), 383–389 (2001).
  • Elia G, Bergman A. Periurethral collagen implant: ultrasound assessment and prediction of outcome. Int. Urogynecol. J. Pelvic Floor Dysfunct. 7(6), 335–338 (1996).
  • Defreitas GA, Wilson TS, Zimmern PE, Forte TB. Three-dimensional ultrasonography: an objective outcome tool to assess collagen distribution in women with stress urinary incontinence. Urology 62(2), 232–236 (2003).
  • Schulz JA, Nager CW, Stanton SL, Baessler K. Bulking agents for stress urinary incontinence: short-term results and complications in a randomized comparison of periurethral and transurethral injections. Int. Urogynecol. J. Pelvic Floor Dysfunct. 15(4), 261–265 (2004).
  • Petrou SP, Lisson SW, Crook JE, Lightner DJ. An exploration into patient preference for injectable therapy over surgery in the treatment of female urinary incontinence. Int. Braz. J. Urol. 32(5), 578–582 (2006).
  • Beggs AD, Irukulla S, Sultan AH, Ness W, Abulafi AM. A pilot study of ultrasound guided Durasphere injection in the treatment of faecal incontinence. Colorectal Dis. 12(9), 935–940 (2010).
  • Altomare DF, La Torre F, Rinaldi M, Binda GA, Pescatori M. Carbon-coated microbeads anal injection in outpatient treatment of minor fecal incontinence. Dis. Colon Rectum 51(4), 432–435 (2008).
  • Maeda Y, Vaizey CJ, Kamm MA. Pilot study of two new injectable bulking agents for the treatment of faecal incontinence. Colorectal Dis. 10(3), 268–272 (2008).
  • Hussain ZI, Lim M, Stojkovic SG. Systematic review of perianal implants in the treatment of faecal incontinence. Br. J. Surg. 98(11), 1526–1536 (2011).
  • McCrery RJ, Appell RA. Safety of carbon bead injection for incontinence in patients taking warfarin. Urology 67(1), 97–99 (2006).
  • Lightner D, Rovner E, Corcos Jet al.; Zuidex Study Group. Randomized controlled multisite trial of injected bulking agents for women with intrinsic sphincter deficiency: mid-urethral injection of Zuidex via the Implacer versus proximal urethral injection of Contigen cystoscopically. Urology 74(4), 771–775 (2009).
  • Hurtado EA, McCrery RJ, Appell RA. Complications of ethylene vinyl alcohol copolymer as an intraurethral bulking agent in men with stress urinary incontinence. Urology 71(4), 662–665 (2008).
  • Erekson EA, Sung VW, Rardin CR, Myers DL. Ethylene vinyl alcohol copolymer erosions after use as a urethral bulking agent. Obstet. Gynecol. 109(2 Pt2), 490–492 (2007).
  • Hurtado E, McCrery R, Appell R. The safety and efficacy of ethylene vinyl alcohol copolymer as an intra-urethral bulking agent in women with intrinsic urethral deficiency. Int. Urogynecol. J. Pelvic Floor Dysfunct. 18(8), 869–873 (2007).
  • Stothers L, Goldenberg SL, Leone EF. Complications of periurethral collagen injection for stress urinary incontinence. J. Urol. 159(3), 806–807 (1998).
  • McKinney CD, Gaffey MJ, Gillenwater JY. Bladder outlet obstruction after multiple periurethral polytetrafluoroethylene injections. J. Urol. 153(1), 149–151 (1995).
  • Malizia AA Jr, Reiman HM, Myers RP et al. Migration and granulomatous reaction after periurethral injection of polytef (Teflon). JAMA 251(24), 3277–3281 (1984).
  • Hanke CW, Higley HR, Jolivette DM, Swanson NA, Stegman SJ. Abscess formation and local necrosis after treatment with Zyderm or Zyplast collagen implant. J. Am. Acad. Dermatol. 25(2 Pt 1), 319–326 (1991).
  • McLennan MT, Bent AE. Suburethral abscess: a complication of periurethral collagen injection therapy. Obstet. Gynecol. 92(4 Pt 2), 650–652 (1998).
  • Palma PC, Riccetto CL, Netto Júnior NR. Urethral pseudolipoma: a complication of periurethral lipo-injection for stress urinary incontinence in a woman. J. Urol. 155(2), 646 (1996).
  • Madjar S, Sharma AK, Waltzer WC, Frischer Z, Secrest CL. Periurethral mass formations following bulking agent injection for the treatment of urinary incontinence. J. Urol. 175(4), 1408–1410 (2006).
  • Abdelwahab HA, Ghoniem GM. Obstructive suburethral mass after transurethral injection of dextranomer/hyaluronic acid copolymer. Int. Urogynecol. J. Pelvic Floor Dysfunct. 18(11), 1379–1380 (2007).
  • Hartanto VH, Lightner DJ, Nitti VW. Endoscopic evacuation of Durasphere. Urology 62(1), 135–137 (2003).
  • Sweat SD, Lightner DJ. Complications of sterile abscess formation and pulmonary embolism following periurethral bulking agents. J. Urol. 161(1), 93–96 (1999).
  • Lai HH, Hurtado EA, Appell RA. Large urethral prolapse formation after calcium hydroxylapatite (Coaptite) injection. Int. Urogynecol. J. Pelvic Floor Dysfunct. 19(9), 1315–1317 (2008).
  • Ko EY, Williams BF, Petrou SP. Bulking agent induced early urethral prolapse after distal urethrectomy. Int. Urogynecol. J. Pelvic Floor Dysfunct. 18(12), 1511–1513 (2007).
  • Ghoniem GM, Khater U. Urethral prolapse after durasphere injection. Int. Urogynecol. J. Pelvic Floor Dysfunct. 17(3), 297–298 (2006).
  • Palma PC, Riccetto CL, Martins MH et al. Massive prolapse of the urethral mucosa following periurethral injection of calcium hydroxylapatite for stress urinary incontinence. Int. Urogynecol. J. Pelvic Floor Dysfunct. 17(6), 670–671 (2006).
  • Harris RL, Cundiff GW, Coates KW, Addison WA, Bump RC. Urethral prolapse after collagen injection. Am. J. Obstet. Gynecol. 178(3), 614–615 (1998).
  • Stenberg AM, Sundin A, Larsson BS, Läckgren G, Stenberg A. Lack of distant migration after injection of a 125iodine labeled dextranomer based implant into the rabbit bladder. J. Urol. 158(5), 1937–1941 (1997).
  • Pannek J, Brands FH, Senge T. Particle migration after transurethral injection of carbon coated beads for stress urinary incontinence. J. Urol. 166(4), 1350–1353 (2001).
  • Tjandra JJ, Chan MK, Yeh HC. Injectable silicone biomaterial (PTQ) is more effective than carbon-coated beads (Durasphere) in treating passive faecal incontinence – a randomized trial. Colorectal Dis. 11(4), 382–389 (2009).
  • Leach GE, Dmochowski RR, Appell RA et al. Female Stress Urinary Incontinence Clinical Guidelines Panel summary report on surgical management of female stress urinary incontinence. The American Urological Association. J. Urol. 158(3 Pt 1), 875–880 (1997).
  • Lightner DJ. Review of the available urethral bulking agents. Curr. Opin. Urol. 12(4), 333–338 (2002).
  • Keegan PE, Atiemo K, Cody J, McClinton S, Pickard R. Periurethral injection therapy for urinary incontinence in women. Cochrane Database Syst. Rev. 3, CD003881 (2007).
  • Chrouser KL, Fick F, Goel A, Itano NB, Sweat SD, Lightner DJ. Carbon coated zirconium beads in beta-glucan gel and bovine glutaraldehyde cross-linked collagen injections for intrinsic sphincter deficiency: continence and satisfaction after extended followup. J. Urol. 171(3), 1152–1155 (2004).
  • El-Shafey el-SI. Complications from repeated injection or puncture of old polyacrylamide gel implant sites: case reports. Aesthetic Plast. Surg. 32(1), 162–165 (2008).
  • Balmforth J, Cardozo LD. Trends toward less invasive treatment of female stress urinary incontinence. Urology 62(4 Suppl. 1), 52–60 (2003).
  • Lose G, Sørensen HC, Axelsen SM, Falconer C, Lobodasch K, Safwat T. An open multicenter study of polyacrylamide hydrogel (Bulkamid®) for female stress and mixed urinary incontinence. Int. Urogynecol. J. 21(12), 1471–1477 (2010).
  • Chapple CR, Haab F, Cervigni M, Dannecker C, Fianu-Jonasson A, Sultan AH. An open, multicentre study of NASHA/Dx Gel (Zuidex) for the treatment of stress urinary incontinence. Eur. Urol. 48(3), 488–494 (2005).
  • Graf W, Mellgren A, Matzel KE, Hull T, Johansson C, Bernstein M; NASHA Dx Study Group. Efficacy of dextranomer in stabilised hyaluronic acid for treatment of faecal incontinence: a randomised, sham-controlled trial. Lancet 377(9770), 997–1003 (2011).
  • Bridges MD, Petrou SP, Lightner DJ. Urethral bulking agents: imaging review. AJR. Am. J. Roentgenol. 185(1), 257–264 (2005).
  • Poon CI, Zimmern PE. Role of three-dimensional ultrasound in assessment of women undergoing urethral bulking agent therapy. Curr. Opin. Obstet. Gynecol. 16(5), 411–417 (2004).
  • Gräs S, Lose G. The clinical relevance of cell-based therapy for the treatment of stress urinary incontinence. Acta Obstet. Gynecol. Scand. 90(8), 815–824 (2011).
  • Dissaranan C, Cruz MA, Couri BM, Goldman HB, Damaser MS. Stem cell therapy for incontinence: where are we now? What is the realistic potential? Curr. Urol. Rep. 12(5), 336–344 (2011).
  • Strasser H, Marksteiner R, Margreiter E et al. Transurethral ultrasonography-guided injection of adult autologous stem cells versus transurethral endoscopic injection of collagen in treatment of urinary incontinence. World J. Urol. 25(4), 385–392 (2007).
  • Kleinert S, Horton R. Retraction – autologous myoblasts and fibroblasts versus collagen [corrected] for treatment of stress urinary incontinence in women: a [corrected] randomised controlled trial. Lancet 372(9641), 789–790 (2008).
  • Zhao W, Zhang C, Jin C et al. Periurethral injection of autologous adipose-derived stem cells with controlled-release nerve growth factor for the treatment of stress urinary incontinence in a rat model. Eur. Urol. 59(1), 155–163 (2011).
  • Wu S, Wang Z, Bharadwaj S, Hodges SJ, Atala A, Zhang Y. Implantation of autologous urine derived stem cells expressing vascular endothelial growth factor for potential use in genitourinary reconstruction. J. Urol. 186(2), 640–647 (2011).
  • Chapple CR, Brubaker L, Haab F, van Kerrebroeck P, Robinson D. Patient-perceived outcomes in the treatment of stress urinary incontinence: focus on urethral injection therapy. Int. Urogynecol. J. Pelvic Floor Dysfunct. 18(2), 199–205 (2007).

Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.